MACCEROL
For the use of a Registered Medical
Practitioner or a Hospital or a Laboratory Only
Abbreviated Prescribing information
for Maccerol (Calcitriol, Calcium Carbonate, Zinc & Magnesium Tablets)
[Please refer the complete prescribing
information available at www.macnispharma.com]
PHARMACOLOGICAL
PROPERTIES: Maccerol soft gelatin capsule is a combination of Calcitriol,
elemental Calcium which is derived from Calcium Carbonate and Zinc.
INDICATIONS:
For the treatment of hypocalcaemia and/or osteoporosis.
DOSAGE
AND ADMINISTRATION: The recommended dose is one capsule of Maccerol daily. Maccerol
Tablets should be administered orally.
CONTRAINDICATIONS: Maccerol should not be
given to patients with hypercalcaemia or evidence of vitamin D toxicity. Use of
Maccerol Tablets in patients with known hypersensitivity to Maccerol Tablets or
any of the inactive ingredients is contraindicated.
WARNINGS
& PRECAUTIONS: Since calcitriol is the most potent metabolite of vitamin D
available, other preparations of vitamin D and its derivatives should be
withheld during treatment. Excessive dosage of this combination may induce
hypercalcaemia and in some instances hypercalciuria. Calcitriol increases
inorganic phosphate levels in serum. While this is desirable in patients with
hypophosphatemia, caution is called for in patients with renal failure because
of the danger of ectopic calcification. Magnesium - containing preparations
(eg, antacids) and calcitriol should not be used concomitantly in patients on
chronic renal dialysis because such use may lead to the development of
hypermagnesemia. Excessive intake of Zinc may lead to overdosage symptoms like
nausea, severe vomiting, dehydration, restlessness and sideroblastic anaemia
(secondary to Zinc induced copper depletion).
DRUG
INTERACTIONS: - It can interact due to concomitant use of magnesium containing
antacids and calcitriol, digitalis, barbiturates or anticonvulsants,
corticosteroids, Cholestyramine, Ketoconazole, verapamil and other calcium
channel blockers, Oestrogens, fluoroquinolones, phenytoin, tetracyclines,
thiazides and phosphate binding agents.
ADVERSE REACTIONS: Early-Weakness, headache,
somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone
pain,anorexia, abdominal pain or stomach ache and metallic taste and metallic
taste. Late - Polyuria, polydipsia, anorexia, weight loss, nocturia,
conjunctivitis (calcific), pancreatitis, photophobia, rhinorrhea, pruritus,
hyperthermia, decreased libido, elevated BUN, albuminuria, hypercholesterolaemia,
elevated SGOT and SGPT, ectopic calcification, hypertension, cardiac
arrhythmias, nephrocalcinosis, dystrophy, sensory disturbances, dehydration,
apathy, arrested growth, urinary tract infections, and rarely, overt psychosis.
MARKETED
BY:
MACNIS PHARMACEUTICALS
J3/31 A-3,3rd
Floor,Khiri Extension.
Malviya Nagar,New Delhi-17
Visit us at: www.macnispharma.com
Reach us at: info@macnispharma.com